MEPERIDINE HYDROCHLORIDE

N/A

Manufactured by Hospira, Inc.

36,000 FDA adverse event reports analyzed

Last updated: 2026-04-14

About MEPERIDINE HYDROCHLORIDE

MEPERIDINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Hospira, Inc.. The most commonly reported adverse reactions for MEPERIDINE HYDROCHLORIDE include DRUG HYPERSENSITIVITY, DRUG INEFFECTIVE, PAIN, NAUSEA, OFF LABEL USE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MEPERIDINE HYDROCHLORIDE.

Top Adverse Reactions

DRUG HYPERSENSITIVITY3,249 reports
DRUG INEFFECTIVE1,271 reports
PAIN1,248 reports
NAUSEA1,132 reports
OFF LABEL USE861 reports
HYPERHIDROSIS821 reports
DRUG INTOLERANCE793 reports
RASH775 reports
VOMITING734 reports
OVERDOSE719 reports
HYPERTENSION677 reports
HEADACHE647 reports
PYREXIA631 reports
FATIGUE608 reports
JOINT SWELLING569 reports
RHEUMATOID ARTHRITIS567 reports
UPPER RESPIRATORY TRACT INFECTION564 reports
INFUSION RELATED REACTION559 reports
HYPERSENSITIVITY549 reports
DRUG DEPENDENCE510 reports
TREATMENT FAILURE492 reports
PSORIASIS491 reports
THROMBOCYTOPENIA490 reports
INFECTION439 reports
EXPOSURE DURING PREGNANCY423 reports
BACK PAIN422 reports
ANXIETY395 reports
ASTHMA392 reports
PRODUCT USE ISSUE382 reports
SEDATION373 reports
NIGHTMARE371 reports
IMMUNODEFICIENCY359 reports
HEPATIC ENZYME INCREASED358 reports
FOOD ALLERGY352 reports
PRESCRIBED OVERDOSE342 reports
INTENTIONAL PRODUCT MISUSE340 reports
DEPENDENCE336 reports
CONSTIPATION334 reports
RASH ERYTHEMATOUS328 reports
NEPHROLITHIASIS321 reports
EMOTIONAL DISTRESS311 reports
DYSPNOEA305 reports
ERYTHEMA300 reports
PRODUCT USE IN UNAPPROVED INDICATION296 reports
FLUID RETENTION292 reports
DIARRHOEA284 reports
DIZZINESS283 reports
CONTRAINDICATED PRODUCT ADMINISTERED277 reports
MALAISE275 reports
ARTHRALGIA261 reports
TEMPERATURE REGULATION DISORDER253 reports
FOETAL DEATH241 reports
PAIN IN EXTREMITY239 reports
URTICARIA238 reports
BURSITIS236 reports
CHEST PAIN232 reports
COELIAC DISEASE224 reports
DEATH220 reports
DEPRESSION220 reports
HERPES ZOSTER217 reports
ABDOMINAL PAIN215 reports
PRURITUS211 reports
FALL199 reports
DRUG WITHDRAWAL SYNDROME187 reports
INSOMNIA187 reports
CONTRAST MEDIA ALLERGY179 reports
ASTHENIA177 reports
HYPOAESTHESIA175 reports
INJURY167 reports
HYPOTENSION165 reports
COUGH160 reports
PNEUMONIA155 reports
INTERNATIONAL NORMALISED RATIO FLUCTUATION153 reports
CHILLS149 reports
RENAL FAILURE145 reports
ABDOMINAL PAIN UPPER142 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE142 reports
FOETAL EXPOSURE DURING PREGNANCY139 reports
WEIGHT DECREASED137 reports
CONFUSIONAL STATE129 reports
SOMNOLENCE128 reports
MATERNAL EXPOSURE DURING PREGNANCY126 reports
FEELING ABNORMAL123 reports
SEPSIS117 reports
TREMOR116 reports
WEIGHT INCREASED116 reports
ANAEMIA115 reports
DRUG WITHDRAWAL SYNDROME NEONATAL114 reports
GASTROOESOPHAGEAL REFLUX DISEASE114 reports
ANAPHYLACTIC REACTION112 reports
DEVELOPMENTAL DELAY111 reports
URINARY TRACT INFECTION111 reports
LEARNING DISABILITY110 reports
OEDEMA PERIPHERAL109 reports
GAIT DISTURBANCE107 reports
MIGRAINE107 reports
ABDOMINAL DISCOMFORT106 reports
DEHYDRATION106 reports
HALLUCINATION106 reports
CEREBROVASCULAR ACCIDENT105 reports

Report Outcomes

Out of 8,979 classified reports for MEPERIDINE HYDROCHLORIDE:

Serious 63.2%Non-Serious 36.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female5,893 (72.9%)
Male2,163 (26.8%)
Unknown27 (0.3%)

Reports by Age

Age 53360 reports
Age 60298 reports
Age 58287 reports
Age 36154 reports
Age 67144 reports
Age 64115 reports
Age 59113 reports
Age 61111 reports
Age 66111 reports
Age 71111 reports
Age 54110 reports
Age 70108 reports
Age 65104 reports
Age 69104 reports
Age 63103 reports
Age 68100 reports
Age 4899 reports
Age 4998 reports
Age 5798 reports
Age 6295 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with MEPERIDINE HYDROCHLORIDE?

This profile reflects 36,000 FDA FAERS reports that mention MEPERIDINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for MEPERIDINE HYDROCHLORIDE?

Frequently reported terms in FAERS include DRUG HYPERSENSITIVITY, DRUG INEFFECTIVE, PAIN, NAUSEA, OFF LABEL USE, HYPERHIDROSIS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures MEPERIDINE HYDROCHLORIDE?

Labeling and FAERS entries often list Hospira, Inc. in connection with MEPERIDINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.